KHC:NASDAQ

The Kraft Heinz Company

Data as of 2026-03-10 - not real-time

$23.66

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kraft Heinz’s stock is trading just above its 20‑day SMA and slightly below its 50‑day SMA, with a neutral trend direction and an RSI around the mid‑40s, indicating limited short‑term momentum. The MACD shows a bearish histogram and the signal line is below the MACD line, while volume has been on a decreasing trend, suggesting weakening buying pressure. Beta is exceptionally low at roughly 0.26, but the 30‑day volatility exceeds 25%, and the recent max drawdown approaches 28%, highlighting a mix of defensive stability and price swing risk. The current market price sits well above the DCF‑derived fair value of about $17, pointing to an overvalued condition despite a high dividend yield of over 6% that may be difficult to sustain given negative trailing earnings and a 73% payout ratio.
Fundamentally, revenue has contracted year‑over‑year and profit margins are negative, though free cash flow remains positive and the company is committing roughly $600 million to brand revitalization. The defensive consumer‑staples sector offers some cushion, and analyst consensus remains “hold,” but the combination of earnings weakness, overvaluation, and mixed technical signals tempers optimism for near‑term upside.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram and signal line
  • Price hovering near immediate support with decreasing volume
  • Current price above DCF fair value indicating overvaluation

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Planned $600 million brand investment to address under‑investment
  • High dividend yield providing income cushion
  • Defensive consumer staples positioning despite earnings weakness

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential turnaround from brand revitalization and cost initiatives
  • Low beta and stable cash flow supporting dividend continuity
  • Persistently negative profit margins and revenue decline limiting growth

Key Metrics & Analysis

Financial Health

Revenue Growth-3.40%
Profit Margin-23.44%
P/E Ratio11.0
ROE-12.84%
ROA3.50%
Debt/Equity52.10
P/B Ratio0.7
Op. Cash Flow$4.5B
Free Cash Flow$2.8B

Technical Analysis

TrendNeutral
RSI42.2
Support$23.44
Resistance$25.20
MA 20$24.39
MA 50$24.01
MA 200$25.59
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value$17.27
Target Price$25.13
Upside/Downside6.22%
GradeOvervalued
TypeValue
Dividend Yield6.55%

Risk Assessment

Beta0.26
Volatility25.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.